logo
In-N-Out Announces Changes After New FDA Guidelines

In-N-Out Announces Changes After New FDA Guidelines

Yahoo21-05-2025
Last month, the Food and Drug Administration announced that it would begin phasing out the use of petroleum-based synthetic dyes in food products by the end of next year. That has forced beloved burger chain In-N-Out to make some changes.
United States Secretary of Health and Human Services Robert F. Kennedy helped spearhead an effort to remove the dyes from food products in the United States.
'For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent,' Kennedy said in a statement at the time. 'These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and development.'
'We're restoring gold-standard science, applying common sense, and beginning to earn back the public's trust. And, we're doing it by working with industry to get these toxic dyes out of the foods our families eat every day.'
As a result of that announcement, In-N-Out announced this week that it will be making some changes to its menu, including the removal of artificial coloring from its Strawberry Shakes and Signature Pink Lemonade as well as the transition to a ketchup that uses real sugar instead of high-fructose corn syrup.
In-N-Out Owner and President Lynsi Snyder announced the changes in a statement to Newsweek.
"We are proud to say we've made the following changes,"
Replaced Yellow 5 with Turmeric in our pickles, chilies, and spread
Replaced Red 40 with beta carotene and vegetable juice in our Strawberry Shakes and Signature Pink Lemonade
Replaced artificial vanilla with natural vanilla in our shake mix
Replaced artificial flavors with natural flavors in our chocolate syrup and hot cocoa
Replaced high-fructose corn syrup with natural sugar in our shake mix, strawberry syrup, spread, and Signature Pink Lemonade
Replaced calcium propionate with natural enzymes in our buns and removed cottonseed oil
"We've additionally introduced a healthier beverage sweetener option by replacing sucralose and saccharin sweetener packets with Stevia Leaf Extract, and added a non-dairy alternative, oat milk creamer, Snyder said.
"We're also in the process of transitioning to ketchup made with real sugar instead of high fructose corn syrup and researching an even better-quality oil for our fries."
In-N-Out is not alone in these changes, as brands across the country will be forced to make changes to comply with the new guidelines.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Robert F. Kennedy Jr. and other Trump officials embrace psychedelics after FDA setback
Robert F. Kennedy Jr. and other Trump officials embrace psychedelics after FDA setback

Chicago Tribune

time23 minutes ago

  • Chicago Tribune

Robert F. Kennedy Jr. and other Trump officials embrace psychedelics after FDA setback

WASHINGTON — For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions. A presidential administration finally seems to agree. 'This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,' Health Secretary Robert F. Kennedy Jr. recently told members of Congress. His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs. And it comes as psychedelics are making inroads in deep red states like Texas, where former Trump cabinet secretary and ex-governor Rick Perry has thrown his full support behind the effort. The administration's embrace of psychedelics has sparked both excitement as well as concern from those in the field, who worry the drugs might be discredited if they appear to be rushed onto the market or are too closely linked with Kennedy, who is known for controversial views on vaccines, antidepressants and fluoride. 'I'm quite optimistic,' says Rick Doblin, whose organization has pursued the medical use of MDMA (or ecstasy) since the 1980s. 'But I'm also worried that the message the public might get is 'Well, RFK likes psychedelics and now it's approved.'' Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and questionable research. Regulators called for a new study, likely taking several years. It was a major setback for Doblin and other advocates hoping to see the first U.S. approval of a psychedelic for medical use. But the agency appears ready to reconsider. FDA chief Marty Makary, who reports to Kennedy, has called the evaluation of MDMA and other psychedelics 'a top priority,' announcing a slate of initiatives that could be used to accelerate their approval. One new program promises to expedite drugs that serve 'the health interests of Americans,' by slashing their review time from six months or more to as little as one month. Makary has also suggested greater flexibility on requirements for certain drugs, potentially waiving rigorous controlled studies that compare patients to a placebo group. That approach, considered essential for high-quality research, has long been a stumbling point for psychedelic studies, in which patients can almost always correctly guess whether they've received the drug or a dummy pill. The U.S. Department of Health and Human Services and FDA also recently hired several new staffers with ties to the psychedelic movement. 'These are all very promising signs that the administration is aware of the potential of psychedelics and is trying to make overtures that they're ready to approve them,' said Greg Ferenstein, a fellow at the libertarian Reason Foundation, who also consults for psychedelic companies. 'We didn't hear anything about that in the Biden administration' A spokesperson for HHS did not respond to a request for comment. As a presidential candidate, Kennedy discussed how his son and several close friends benefited from using psychedelics to deal with grief and other issues. A number of veterans lobbying for psychedelic access have already met with Trump's Secretary of Veterans Affairs, Doug Collins. 'What we're seeing so far is positive,' Collins told House lawmakers in May. But some experts worry the hope and hype surrounding psychedelics has gotten ahead of the science. Philip Corlett, a psychiatric researcher at Yale University, says bypassing rigorous clinical trials could set back the field and jeopardize patients. 'If RFK and the new administration are serious about this work, there are things they could do to shepherd it into reality by meeting the benchmarks of medical science,' Corlett said. 'I just don't think that's going to happen.' As officials in Washington weigh the future of psychedelics, some states are moving ahead with their own projects in hopes of nudging the federal government. Oregon and Colorado have legalized psychedelic therapy. And last month, Texas approved $50 million to study ibogaine, a potent psychedelic made from a shrub that's native to West Africa, as a treatment for opioid addiction, PTSD and other conditions. The research grant — the largest of its kind by any government — passed with support from the state's former GOP governor, Perry, and combat veterans, some who have traveled to clinics in Mexico that offer ibogaine. Ibogaine is on the U.S. government's ultra-restrictive list of illegal, Schedule 1 drugs, which also includes heroin. So advocates in Texas are hoping to build a national movement to ease restrictions on researching its use. 'Governmental systems move slowly and inefficiently,' said Bryan Hubbard of Americans for Ibogaine, a group formed with Perry. 'Sometimes you find yourself constrained in terms of the progress you can make from within.' Ibogaine is unique among psychedelics in both its purported benefits and risks. Small studies and anecdotal reports suggest the drug may be able to dramatically ease addiction and trauma. It was sold for medical use in France for several decades starting in the 1930s, but the drug can also cause dangerous irregular heart rhythms, which can be fatal if left untreated. Some veterans who have taken the drug say the risks can be managed and ibogaine's healing properties go far beyond antidepressants, mood stabilizers, counseling and other standard treatments. Marcus Capone struggled with anger, insomnia and mood swings after 13 years as a Navy Seal. In 2017, at the urging of his wife Amber, he agreed to try ibogaine as a last resort. He described his first ibogaine session as 'a complete purge of everything.' 'But afterward I felt the weight just completely off my shoulders,' he said. 'No more anxiety, no more depression, life made sense all of a sudden.' A nonprofit founded by the Capones, Veterans Exploring Treatment Solutions, or VETS, has helped over 1,000 veterans travel abroad to receive ibogaine and other psychedelics. But federal scientists have looked at the drug before — three decades ago, when the National Institute on Drug Abuse funded preliminary studies on using it as an addiction treatment. The research was discontinued after it identified 'cardiovascular toxicity.' 'It would be dead in the water,' in terms of winning FDA approval, longtime NIDA director Nora Volkow said. But Volkow said her agency remains interested in psychedelics, including ibogaine, and is funding an American drugmaker that's working to develop a safer, synthetic version of the drug. 'I am very intrigued by their pharmacological properties and how they are influencing the brain,' Volkow said. 'But you also have to be very mindful not to fall into the hype and to be objective and rigorous in evaluating them.'

RFK Jr. fires 2 top aides at HHS in staff shakeup
RFK Jr. fires 2 top aides at HHS in staff shakeup

Yahoo

time35 minutes ago

  • Yahoo

RFK Jr. fires 2 top aides at HHS in staff shakeup

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has fired two of his top aides. The biographies of Heather Flick Melanson, his chief of staff, and Hannah Anderson, deputy chief of staff of policy, are no longer pictured on the department's leadership page. "Secretary Kennedy has made a leadership change within the Immediate Office of the Secretary," an Hhs spokesperson told Fox News Digital. "Effective immediately, Matt Buckham will serve as Acting Chief of Staff." "Mr. Buckham currently serves as the Kennedy's White House liaison at the U.S. Department of Health and Human Services, where he oversees the recruitment and onboarding of political appointees across the agency. He brings valuable experience in personnel strategy and organizational management to this new role," the spokesperson added. Biden-appointed Judge Halts Trump Hhs Overhaul After Democrat-led Lawsuit "Secretary Kennedy thanks the outgoing leadership for their service and looks forward to working closely with Mr. Buckham as the Department continues advancing its mission to Make America Healthy Again," the spokesperson also said. Read On The Fox News App Melanson is a lawyer who previously served in multiple top roles at HHS during the first Trump administration. Medical Groups Urge Kennedy, Fda To Reexamine Broad Approval Of Abortion Drugs She previously was HHS' acting general counsel before becoming its acting secretary for administration and then eventually a senior adviser to then-HHS Secretary Alex Azar. Prior to joining HHS for the first time, Flick was an attorney at Dhillon Law Group, a firm founded by Harmeet Dhillon, who Trump has tapped this time around to be his assistant attorney general. "Heather Flick is outstanding and will most definitely help soon to be Secretary of Health and Human Services Robert F. Kennedy Jr.," former Trump National Security Adviser Michael Flynn said in a post on X after news of Flick's new role. Fox News Digital's Alec Schemmel contributed to this report. Original article source: RFK Jr. fires 2 top aides at HHS in staff shakeup

5.4 million hit in major healthcare data breach — names, emails, SSNs and more exposed
5.4 million hit in major healthcare data breach — names, emails, SSNs and more exposed

Yahoo

timean hour ago

  • Yahoo

5.4 million hit in major healthcare data breach — names, emails, SSNs and more exposed

When you buy through links on our articles, Future and its syndication partners may earn a commission. Hackers continue to go after healthcare-related businesses in their attacks and unfortunately, you could easily get caught up in the aftermath as the result of a data breach. Case in point, millions of Americans are now receiving data breach notifications in the mail following a cyberattack on a medical billing company earlier this year. As reported by BleepingComputer, back in January and early February, hackers stole the personal and medical information of 5.4 million people during a cyberattack at the American healthcare services company Episource. While you likely haven't heard of this company, which is owned by UnitedHealth Group's Optum subsidiary, it provides risk adjustment, medical coding, data analytics and other tech to healthcare providers. As a result, Episource often handles large troves of personal and medical data which makes it a valuable target for hackers and other cybercriminals. Now though, the company has begun notifying affected individuals that their personal and medical data could be in the hands of hackers. Here's everything you need to know about this major medical data breach along with what to do next and steps to help keep you safe from any follow-up attacks. Personal and medical data exposed The hackers behind this attack managed to gain access to Episource's systems at the beginning of the year and according to a data breach notice on its site, the breach likely occurred sometime between January 27th and February 6th. During that time, the hackers were able to view as well as steal copies of some data in the company's computer systems. While the exposed data varies from person to person, it may include one or more of the following: Full name Physical address Email address Phone number Insurance plan information Medicaid ID and information Medical record details Date of birth Social Security number Fortunately though, no banking or payment card information was exposed as a result of the breach. In a filing with the U.S. Department of Health and Human Service's Office for Civil Rights, Episource revealed that approximately 5,418,886 people are affected. The company began sending out data breach notifications to impacted individuals in April but as TechCrunch points out in a new report, additional notices have since been filed in California and Vermont and more people are now being notified in regard to this breach. How to stay safe after a data breach With patients' full names, addresses, emails, phone numbers, dates of birth and especially their Social Security numbers in hand, there's a whole lot that hackers can do. From committing fraud and even identity theft to launching targeted phishing attacks using this stolen data, those impacted by this breach are going to need to be extra careful when answering their phones, checking their mailboxes and looking at their email. Episource is taking steps to soften the blow of this breach by providing affected individuals with free access to the best identity theft protection services. In the company's data breach notification shared (PDF) with the Office of the Vermont Attorney General, it explained that people whose medical and personal data was exposed can sign up for credit monitoring and identity restoration services from IDX which can be done so online or over the phone. If you're worried that your personal data and medical info could have been exposed, you're going to want to keep a close eye on your mailbox. The reason being is that instead of over email, data breach notification letters are typically sent via traditional mail. This letter will have all the details on how to sign up for IDX's identity theft protection and credit monitoring. However, it will also let you know exactly what types of your data were exposed in this breach. At the same time, you may also want to freeze your credit since with all this sensitive data, hackers could try to take out loans in your name or commit other types of fraud. You're also going to want to be extra careful when dealing with text messages or emails from unknown senders since other cybercriminals with access to this data could try to launch follow-up attacks, likely in the form of phishing scams. Likewise, monitoring all of your financial accounts is highly recommended as fraud is a lot easier to deal with when you spot it early on. Now that hackers have made it a point to go after healthcare-related businesses and healthcare providers, hopefully the entire medical industry is working on strengthening their security. In the meantime though, you want to make sure that all of your devices are protected with the best antivirus software and that you're using strong and complex passwords for all of your accounts. By taking these steps and improving your own cyber hygiene, you'll be better prepared for when the next data breach happens. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide Google Gemini flaw exploited to turn AI-powered email summaries into the perfect phishing tool Nearly 2 million people hit by malicious Chrome installations that can track you — what to do now This dangerous banking trojan now uses scheduled maintenance to hide its malicious activities — don't fall for this Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store